1. Summarize the magnitude of clinical benefit with immune checkpoint inhibition
  2. Evaluating emerging mechanisms of resistance to immune checkpoint inhibition
  3. Proposing new approaches to enhance the efficacy of immune checkpoint inhibition

Zoom details:



Session date: 
05/18/2022 - 8:00am to 9:00am CDT
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Dr. Larry Fong